Preclinical study demonstrates that a thermoresponsive amifostine biogel prevents radiation-induced rectal injury, highlighting a targeted strategy for radioprotection.
Radiation-induced rectal injury (RRI) limits radiotherapy and results in a poor clinical prognosis. In this study, we report a radioprotective strategy for preventing RRI using a thermoresponsive amifostine-loaded chitosan biogel. Specifically, the biogel is synthesized via the reaction of crocetin with cysteine-modified chitosan and sodium alginate, followed by incorporating amifostine-sodium glycerophosphate solution. The storage modulus increases markedly at the gel point of ∼30 °C. The biogel possesses favorable biocompatibility in vitro and maintains the ability of cells to migrate and proliferate after 8 Gy irradiation. Meanwhile, it possesses good stability in artificial intestinal fluid and can slowly release amifostine for more than 12 h. With the aid of endoscopy, the biogel can be precisely delivered to the colorectal region and alleviates RRI by promoting mucosal recovery, enhancing crypt activity, and modulating inflammation. In addition, the biogel shows a trend toward increasing the abundance of gut flora and the counts of probiotics, thereby maintaining gut microbial homeostasis. This work provides a simple yet transformative tactic by the thermoresponsive biogel, and presents a promising avenue for clinical prevention of RRI.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: